相关实验视频

Updated: Jul 1, 2025

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

高血栓激活纤维解酶抑制剂表达在高雌激素状态中中风患者的血栓中

Tamanna Agarwal¹, Oana Madalina Mereuta², Sherief Ghozy³

¹Faculty of Medicine in Hradec Kralove, Charles University, Prague, Czech Republic.

|March 8, 2024

概括

在急性缺血性中风 (AIS) 中,高雌激素状态会增加血栓激活性纤维解酶抑制剂 (TAFI). 这有助于在患有雌激素水平升高的患者中更难去除血块.

科学领域:

神经学神经学
血液学血液学血液学
内分泌学在内分泌学.

背景情况:

高雌激素状态,包括怀孕和口服避孕药的使用,与急性缺血性中风 (AIS) 的风险增加有关.
在这些条件下,瘤的特定组织学特征需要进一步调查.

研究的目的:

为了研究患有高雌激素状态和AIS的患者中瘤的组织成分.
为了比较患有高雌激素状态的患者和匹配的对照组之间的血栓组成.

主要方法:

来自5名患有高雌激素状态 (产后,激素替代疗法,口服避孕药) 和5名年龄相匹配的男性对照者的血栓分析.
免疫组织化学被用来评估血小板的表达 (CD42b),·威尔布兰德因子 (vWF),血栓激活性纤维解酶抑制剂 (TAFI),纤维素原和等离子素激活剂抑制剂-1 (PAI-1).
测量了表达水平,并进行了统计分析 (学生的t测试).

主要成果:

与对照组相比,高雌激素组中的血栓显示出明显更高的TAFI含量 (25.6%与9.3%,p=0.043) 和较低的血小板含量 (41.7%与61.8%,p=0.029).
没有观察到群体之间的vWF,纤维素素或PAI-1表达的显著差异.
机械血栓切除在高雌激素组的效率较低,由更长的再通道化时间 (57.8分 vs 22.6分,p=0.035) 和需要更多的传递 (4.6对1.2,p=0.026) 表示.

结论:

在AIS血栓中TAFI表达升高与高雌激素状态有关.
较高的TAFI水平可能导致这些患者观察到的凝块去除难度增加.
这些发现突出了一个潜在的机制,将雌激素,TAFI和中风病理生理学联系起来.

关键词:

雌激素是一种雌激素.这是OCP.一次性中风,中风.塔菲 (TAFI) 是一个数字.进行血栓切除术 (thrombectomy).

更多相关视频

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Published on: September 25, 2016

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

Published on: February 13, 2013

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...